Trial Profile
Sorafenib +/- percutaneous radiofrequency ablation in patients with liver cancer and portal vein tumour thrombus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2011
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 03 Apr 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
- 01 Apr 2011 New trial record